Medix Biochemica is a Finnish biotechnology company that develops, produces, and markets monoclonal antibodies, antibody service and antigens for IVD industry as well as diagnositic rapid test for human healthcare worldwide. When we started the industrial-scale manufacturing of monoclonal antibodies over 30 years ago, we create a new paradigm for the antibody industry. In 2019, we acquired Lee Biosolutions, a US based company focus on providing high quality native antigen for IVD industry. Now our product range covers monoclonal antibodies and antigens for a variety of markers. Our long-term aim is to become the #1 supplier of critical raw materials for IVD test manufacturers.